Skip to main content
. Author manuscript; available in PMC: 2013 May 10.
Published in final edited form as: Pharmacotherapy. 2011 Jul;31(7):678–685. doi: 10.1592/phco.31.7.678

Table 4.

Bleeding complications and postpartum anticoagulation

Parameter Prophylaxis n=13 Therapeutic n=40
Switched to heparin sodium for delivery (n,%) (n=12) * 5 (38.5%) (n=36) 10 (27.8%)
Time from last injection to delivery (hours, mean ± SD, range) n = 11
48 ± 12 (20–168)
n = 33
38 ± 25 (6–144)
Time from delivery until anticoagulation restarted (hours, avg ± SD range) n = 10
37 ± 42 (12 – 52)
n=35
17 ± 10 (3 – 48)
Postpartum anticoagulation (n, %) n = 12 n = 39
 LMWH alone 0 4 (10%)
 LMWH and warfarin 9 (75%) 30 (77%)
 LMWH, warfarin, and heparin 1 (8.3%) 2 (5.1%)
 None 2 (16.7%) 0
 Heparin + warfarin 0 3 (7.7%)
Major Bleeding (n, %) 2 (15.4%) 1 (2.5%)
Minor Bleeding (n, %) 2 (15.4%) 8 (20%)
Bruising (n, %) 4 (30.8%) 22 (55%)
Thromboembolism (n, %) 1 (7.7%) 1 (2.5%)
*

n = 12 since one patient transferred her care to another facility at 28 weeks

n = 11, data missing on remaining 2 patients

n = 36 since 2 patients terminated pregnancy, 1 patient had therapy discontinued before delivery and 1 patient lost to follow up